Diabetes care in Norwegian pharmacies: a descriptive study
- 189 Downloads
Objective To describe Norwegian pharmacies’ involvement in diabetes care, to investigate pharmacists’ views on future services and to investigate whether the recommendations in the Norwegian diabetes declaration for pharmacies have been implemented. Setting Hospital and community pharmacies in Norway. Method All 543 pharmacies in Norway, of which 511 were community pharmacies and 32 were hospital pharmacies, received a link to a web-based questionnaire. One pharmacist from each pharmacy was asked to complete the questionnaire. The questionnaire covered subjects ranging from the diabetes declaration and the pharmacists’ views on which services the pharmacy should offer in the future, to demographic characteristics. Results In total 358 (66%) questionnaires were completed. The diabetes declaration was read by 37% of the pharmacists. Almost all pharmacies complied with the declarations’ recommendations regarding glucose monitoring services. Twenty four percent of the pharmacies could offer medication reviews, and roughly 10% could offer screening for undiagnosed diabetes. Counseling on lifestyle issues was the least implemented recommendation. Eighty one percent of the pharmacists reported a wish to expand their services towards diabetes patients. Services in regard to glucose monitoring had the highest score, however the views on which services should be offered varied a great deal. Already performing a service increased the chance of the pharmacist being positive towards offering it. Conclusion Norwegian pharmacists report that they are involved in a wide range of diabetes related services, although only 37% report to have read the diabetes declaration. The pharmacists generally wish to actively support patients with diabetes, and further research should concentrate on identifying the areas where their involvement is most productive.
KeywordsPharmacy services Diabetes Mellitus Pharmacists Glucose monitoring Questionnaires Norway
The authors would like to thank Finn Steen for help with the web questionnaire design and administration. Work presented as an abstract at the 2nd Nordic Social Pharmacy and Health Services Research Conference, Lahti, Finland, November 2005.
- 2.Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001;(1):CD001481.Google Scholar
- 3.Intensive diabetes management: implications of the DCCT, UKPDS. Diabetes Educ 2002;28(5):735–40.Google Scholar
- 5.Schapansky LM, Johnson JA. Pharmacists’ attitudes toward diabetes. J Am Pharm Assoc (Wash ) 2000;40(3):371–7.Google Scholar
- 12.Snella KA. Pharmacy-and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc (Wash) 2006;46(3):370–7.Google Scholar
- 14.Granås AG, Berg CL. Type 2-diabetes: Hva kan apotekene bidra med? [type 2 diabetes: what can the pharmacies contribute]. Diabetes Forum 2004;1:36–7.Google Scholar
- 15.Norges Diabetesforbund [homepage on the internet]. The role of Norwegian pharmacies in the prevention and treatment of diabetes. Joint declaration from the Norwegian Diabetes Association, the Norwegian Pharmacy Association and the Interest group Diabetes in the Pharmacy. http://www.diabetes.no/index.asp?id=26256 (27 Jul 2005).
- 18.Norges Apotekerforening. Apotek og legemidler 2006 - bransjestatistikk om apotekenes virksomhet og rammevilkår [Pharmacy and drugs 2006]. Oslo: Norges Apotekerforening; 2006. ISBN 82-990739-2-8.Google Scholar
- 19.Norges Apotekerforening [homepage on the internet]. Bransjestatistikk [Trade statistics]. http://www.apotek.no (28 Jul 2005).
- 20.Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy (New York) 2005;75(1):9–17.Google Scholar
- 21.Tine Dommerud [homepage on the internet]. Apotek som miniklinikker [Pharmacies as mini-clinics]. http://www.dagensmedisin.no/nyheter/ (23 May 2007).
- 22.Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990;7(4):360.Google Scholar
- 23.Claudi T, Midthjel K, Cooper J, Daae C, Furuseth K, Hanssen KF [monograph on the internet]. NSAMs handlingsprogram for diabetes [NSAMs’ diabetes plan of action]. http://www.nsamdiabetes.no/ (26 Jul 2005) .
- 24.Ministry of health and care services [report on the internet]. [National strategy for the area of diabetes 2006–2010]. http://www.regjeringen.no/en/dep/hod/Documents/rapporter_planer/rapporter/2006/Nasjonal-strategi-for-diabetesomradet-2006–2010.html?id=106611 (30 May 2007).
- 25.Stewart D, O’Shea J, McCaig D. Agreement of practitioners with the recommendations of the ‘Guidelines for Community Pharmacists on the Care of Patients with Diabetes’. J Soc Adm Pharm 2003;20(1):13–7.Google Scholar
- 29.Masood N, Armour C, Krass I. Identifying potential medication related interventions in type 2 diabetes: a mechanism for enhanced community pharmacy services. J Soc Adm Pharm 2002;19(5):170–9.Google Scholar
- 31.Department of Health [homepage on the internet]. Dawn of new era for pharmacy. http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotices/fs/en?CONTENT_ID=4107503&chk=SL9Ji9 (4 Oct 2006).
- 32.Standards of medical care in diabetes–2006. Diabetes Care 2006; 29(Suppl)1:S4–42.Google Scholar
- 34.Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc (Wash) 2000;40(6):773–9.Google Scholar